<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">From the available evidence [
 <xref rid="bib16" ref-type="bibr">16</xref>,
 <xref rid="bib25" ref-type="bibr">[25]</xref>, 
 <xref rid="bib26" ref-type="bibr">[26]</xref>, 
 <xref rid="bib27" ref-type="bibr">[27]</xref>, 
 <xref rid="bib28" ref-type="bibr">[28]</xref>] and to put the things in to perspective, it is logical as well as advisable (but not superseding any recommendation, if any) that – a. for the rapid screening of SARS-CoV-2 carriers (symptomatic or asymptomatic), combined IgM- IgG-ELISA may offer a better utility and sensitivity, compared to a either a IgM- or IgG-ELISA test alone. b. all symptomatic subjects or contacts should be assessed with rapid antibody testing first, if positive then RT-PCR should be done as the confirmatory test. c. all highly suspicious cases should undergo RT-PCR first, even if the rapid antibody tests are negative. d. If antibody test is negative initially, it should be re-tested after 7–10 days.
</p>
